DEFINITIVE PROXY

Company

Phio Pharmaceuticals Corp.

Filed

November 30, 2022

Period of Report

January 4, 2023

Accession Number

0001683168-22-008106

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →